Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines

Journal of Investigative Dermatology

Volumn 126, Issue 8, 2006, Pages 1784-1791

  Funding, Anne T ^a   Johansen, Claus ^a   Kragballe, Knud ^a   Otkjær, Kristian ^a   Jensen, Uffe B ^b   Madsen, Mogens W ^c   Fjording, Marianne S ^c   Finnemann, Jørgen ^c   Skak Nielsen, Tine ^c   Paludan, Søren R ^b   Iversen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c LEO Pharma ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; AUTACOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOFECTAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SERINE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; EPIDERMIS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; INCUBATION TIME; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; WESTERN BLOTTING;

ADULT; ANISOMYCIN; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOKINES; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; NUCLEAR PROTEINS; PROTEIN SYNTHESIS INHIBITORS; PSORIASIS; PYRIDINES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746139320     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700252     Document Type: Article

References (33)

1. Arthur JSC, Cohen P (2000) MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482:44-8
2. Arthur JSC, Fong AL, Dwyer JM, Davare M, Reese E, Obrietan K et al. (2004) Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins. J Neurosci 24:4324-32
3. Barros LF, Young M, Saklatvala J, Baldwin SA (1997) Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells. J Physiol (London) 504:517-25
4. Caivano M, Cohen P (2000) Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J Immunol 164:3018-25
5. Chong YH, Shin YJ, Suh YH (2003) Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: Involvement of multiple intracellular pathways and cyclic AMP response element binding protein. Mol Pharmacol 63:690-8
6. Christophers E (2001) Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol 26:314-20
7. Deak M, Clifton AD, Lucocq JM, Alessi DR (1998) Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17:4426-41
8. Gustin JA, Pincheira R, Mayo LD, Ozes ON, Kessler KM, Baerwald MR et al. (2004) Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells. Am J Physiol Cell Physiol 286:C547-55
9. Ikewaki N, Inoko H (2002) A very late activating antigen-alpha 4 (CD49d) monoclonal antibody, BU49 induces phosphorylation of a cAMP response element-binding protein (CREB), resulting in induction of homotypic cell aggregation and enhancement of interleukin-8 (IL-8) production. Microbiol Immunol 46:685-95
10. Johansen C, Flindt E, Kragballe K, Henningsen J, Westergaard M, Kristiansen K et al. (2005a) Inverse regulation of the nuclear factor-kappa B binding to the p53 and interleukin-8 kappa B response elements in lesional psoriatic skin. J Invest Dermatol 124:1284-92
11. Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen MW et al. (2006) Protein expression of TNF-α in psoriatic skin is regulated at a post-transcriptional level by MK2. J Immunol 176:1431-8
12. Johansen C, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L (2003) 1 Alpha,25-dihydroxyvitamin D-3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes. J Invest Dermatol 120:561-70
13. Johansen C, Kragballe K, Rasmussen M, Dam TN, Iversen L (2004) Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. Br J Dermatol 151:600-7
14. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L (2005b) The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 152:37-42
15. Kragballe K, Desjarlais L, Marcelo CL (1985) Increased DNA-synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol 112:263-70
16. Krueger JG, Krane JF, Carter DM, Gottlieb AB (1990) Role of growth-factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:S135-40
17. Kuprash DV, Udalova IA, Turetskaya RL, Kwiatkowski D, Rice NR, Nedospasov SA (1999) Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J Immunol 162:4045-52
18. Lee CW, Nam JS, Park YK, Choi HK, Lee JH, Kim NH et al. (2003) Lysophosphatidic acid stimulates CREB through mitogen- and stress-activated protein kinase-1. Biochem Biophys Res Commun 305:455-61
19. Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V et al. (2005) Differential expression of phosphorylated NF-kappa B/RelA in normal and psoriatic epidermis and downregulation of NF-kappa B in response to treatment with etanercept J Invest Dermatol 124:1275-83
20. London FS (2003) The protein kinase C inhibitor RO318220 potentiates thrombin-stimulated platelet-supported prothrombinase activity. Blood 102:2472-81
21. Mccoy CE, Campbell DG, Deak M, Bloomberg GB, Arthur JSC (2005) MSK1 activity is controlled by multiple phosphorylation sites. Biochem J 387:507-17
22. McKenzie RC, Sabin E (2003) Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 12:337-45
23. Morel C, Ibarz G, Oiry C, Carnazzi E, Berge G, Gagne D et al. (2005) Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase. J Biol Chem 280:21384-93
24. New L, Zhao M, Li YQ, Bassett WW, Feng Y, Ludwig S et al. (1999) Cloning and characterization of RLPK, a novel RSK-related protein kinase. J Biol Chem 274:1026-32
25. Pang L, Sawada T, Decker SJ, Saltiel AR (1995) Inhibition of Map kinase kinase blocks the differentiation of Pc-12 cells induced by nerve growth-factor. J Biol Chem 270:13585-8
26. Persson E, Voznesensky OS, Huang YF, Lerner UH (2005) Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappa B, in mouse calvarial osteoblasts. Bone 37:513-29
27. Ravichandran KS, Burakoff SJ (1994) Evidence for differential intracellular signaling via Cd4 and Cd8 molecules. J Exp Med 179:727-32
28. Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-6
29. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-44
30. Saklatvala J (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4:372-7
31. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-kappa B p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22:1313-24
32. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JSC (2002) MSK1 and MSK2 are required for the mitogen-and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 22:2871-81
33. Zhong SP, Jansen C, She QB, Goto H, Inagaki M, Bode AM et al. (2001) Ultraviolet B-induced phosphorylation of histone H3 at serine 28 is mediated by MSK1. J Biol Chem 276:33213-9